Trulieve Cannabis Corp. is set to announce its latest quarterly earnings on Wednesday, May 6th, with a consensus estimate EPS of -0.0525.
Today, Trulieve Cannabis Corp. (TCNNF) is priced at $9.6, marking an 1.91% increase from the previous close. The asset has seen a trading volume of $110,860, surpassing the average by 34.88%.
TCNNF has been on a positive streak for three consecutive days, showing a 27.66% increase from the price of $7.52.
In the last quarterly report on February 25th, Trulieve Cannabis Corp. reported a net income of -$43.56 million with an EPS of -23 cents.
The company witnessed a net change in cash of -$194.60 million, primarily due to debt repayment of $253.52 million. Operating cash flow stood at $60 million.
Trulieve Cannabis Corp. generated a revenue of $297.65 million, resulting in a gross profit of $147.98 million. The company reported an EBITDA of $62.23 million.
Key ratios include a gross profit margin of 49.72%, return on equity of -3.76, and a price to sales ratio of 5.56.
With total assets amounting to $2.75 billion and total liabilities at $1.61 billion, Trulieve Cannabis Corp. showcases a robust financial position.
This comprehensive analysis highlights Trulieve Cannabis Corp.'s strong performance and financial standing in the current market session.
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. As of March 16, 2022, it operated 162 dispensaries, which included 113 dispensaries in Florida, 19 affiliated dispensaries in Pennsylvania, 17 dispensaries in Arizona, five dispensaries in California, three dispensaries in Maryland, two dispensaries in Massachusetts, two dispensaries in West Virginia, and one dispensary in Connecticut. Trulieve Cannabis Corp. also operated cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.